Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Farmaco ; 58(2): 121-7, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12581778

RESUMEN

Some 3,3'-(1-piperidino)substituted methylene-bis-isoxazoles were prepared via Mannich base and tested to verify their antiinflammatory-related activity. Human neutrophils stimulated with either PMA and f-MLP were used as the cellular model. The efficiency of eight differently substituted compounds (2-9) was established on their capacity to reduce the O(2)(-) production by activated human neutrophils. The rising hydrophobicity in the side-chain of methylene-bis-isoxazoles leads to a distinction in the neutrophil response against the two stimuli, favoring the inhibition of the PMA elicited cell activation and leaving inaffected the f-MLP induced cell responses. Compounds 8 and 9 are particularly active and abolish almost completely the neutrophil activation in the presence of PMA stimulus.


Asunto(s)
Isoxazoles/síntesis química , Leucocitos/efectos de los fármacos , Metano/análogos & derivados , Metano/síntesis química , Piperidinas/síntesis química , Humanos , Hidrocarburos , Isoxazoles/farmacología , Leucocitos/fisiología , Metano/farmacología , Piperidinas/farmacología
2.
J Biol Chem ; 276(42): 38426-32, 2001 Oct 19.
Artículo en Inglés | MEDLINE | ID: mdl-11485997

RESUMEN

Hypertensive rats from the Milan strain show a significant decrease in calpastatin activity as compared with normotensive control animals. Calpastatin deficiency is age-related and highly relevant in kidney, heart, and erythrocytes and of minor entity in brain tissue. In normotensives the changes during aging in the levels of calpastatin activity and mRNA are consistent with an increase of calpastatin protein. In hypertensive rats such a relationship during aging is not observed, because a progressive accumulation of mRNA is accompanied by a lower amount of calpastatin protein as compared with control rats. Together with the low level of calpastatin in kidney of hypertensive rats, a progressive accumulation of an active 15-kDa calpastatin fragment, previously shown to represent a typical product of calpain-mediated calpastatin degradation, is also observed. Evidence for such intracellular proteolysis by Ca(2+)-activated calpain is provided by the normalization of the calpastatin level, up to that of control animals, in hypertensive rats treated with drugs known to reduce both blood pressure and intracellular Ca(2+) influx. Further evidence is provided by the disappearance, in these conditions, of the 15-kDa calpastatin fragment. These data allow the conclusion that calpastatin degradation is a relevant part of the overall mechanism for regulating calpain activity.


Asunto(s)
Envejecimiento , Proteínas de Unión al Calcio/química , Proteínas de Unión al Calcio/metabolismo , Hipertensión/metabolismo , Riñón/metabolismo , Factores de Edad , Animales , Encéfalo/metabolismo , Cromatografía por Intercambio Iónico , Regulación hacia Abajo , Electroforesis en Gel de Poliacrilamida , Eritrocitos/metabolismo , Immunoblotting , Modelos Biológicos , Miocardio/metabolismo , ARN Mensajero/metabolismo , Ratas , Distribución Tisular
3.
Eur J Med Chem ; 36(11-12): 851-61, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11755228

RESUMEN

Some unsymmetrical derivatives of benzopyrans 9 were synthesized and tested to verify their PKC inhibitory activity. For this purpose, the Mannich bases of 7-hydroxycoumarins 6 were treated with 2-(dialkylamino)benzopyran-4-ones or 3-(dialkylamino)naphtho[2,1-b]pyran-1-ones 8 in the presence of acetic or propionic anhydride, yielding compounds 9. Human neutrophils stimulated with either PMA and f-MLF were used as the cellular model. The efficiency of the compounds 9 was established on their capacity to reduce the O(2)(-) production by activated human neutrophils. Compounds 9d and 9f, bearing an acetoxy group in position 7 of the chromone moiety, seem to counteract the neutrophil activation efficiently.


Asunto(s)
Antiinflamatorios/síntesis química , Cromonas/síntesis química , Neutrófilos/efectos de los fármacos , Antiinflamatorios/química , Antiinflamatorios/farmacología , Benzopiranos/síntesis química , Benzopiranos/química , Benzopiranos/farmacología , Cromonas/química , Cromonas/farmacología , Humanos , N-Formilmetionina Leucil-Fenilalanina/farmacología , Naftalenos/síntesis química , Naftalenos/química , Naftalenos/farmacología , Neutrófilos/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Relación Estructura-Actividad , Acetato de Tetradecanoilforbol/farmacología
4.
Biochem Biophys Res Commun ; 272(2): 472-6, 2000 Jun 07.
Artículo en Inglés | MEDLINE | ID: mdl-10833437

RESUMEN

In this paper, we have further analyzed the properties of calpain activator (CA) in order to better define its physiological function. The activator shows a pH optimum approximately 7.8-8.0, independently of the nature of the buffer used. Although the maximal activity is observed with human acid-denatured globin, the effect of CA is detectable with other protein substrates, such as casein and insulin. A comparable activating effect is observed also with the synthetic substrate Succ-Leu-Tyr-AMC. The activatory effect has been evaluated in a reconstructed system, using plasma membrane Ca(2+)-ATPase as substrate. CA is localized in erythrocyte precursor cells on the inner surface of the plasma membrane in very high amount and its level profoundly decreases up to 10% of the original value when cells reach the terminal differentiated state.


Asunto(s)
Calpaína/metabolismo , Activadores de Enzimas/metabolismo , Proteínas de la Membrana/metabolismo , Proteínas/metabolismo , Animales , Tampones (Química) , ATPasas Transportadoras de Calcio/metabolismo , Caseínas/metabolismo , Diferenciación Celular , Activación Enzimática/efectos de los fármacos , Activadores de Enzimas/farmacología , Membrana Eritrocítica/metabolismo , Eritrocitos/citología , Eritrocitos/metabolismo , Células Precursoras Eritroides/citología , Células Precursoras Eritroides/metabolismo , Globinas/metabolismo , Humanos , Concentración de Iones de Hidrógeno , Insulina/metabolismo , Proteínas de la Membrana/farmacología , Ratones , Desnaturalización Proteica , Proteínas/farmacología , Ratas , Especificidad por Sustrato/efectos de los fármacos , Células Tumorales Cultivadas
6.
J Biol Chem ; 275(1): 82-6, 2000 Jan 07.
Artículo en Inglés | MEDLINE | ID: mdl-10617589

RESUMEN

Acyl-CoA-binding protein, a 20-kDa homodimer that exerts many physiological functions, promotes activation of the classic calpain forms, most markedly that of the m-isozyme. This protein factor was purified from rat skeletal muscle and was also expressed in Escherichia coli. Both native and recombinant acyl-CoA-binding proteins show the same molecular properties and an identical capacity to decrease the [Ca(2+)] required for m-calpain activity. The binding of long-chain acyl-CoAs to acyl-CoA-binding protein does not modify the activating effect on calpains. Acyl-CoA-binding protein seems to be involved in the m-calpain regulation process, whereas the previously identified UK114 activator is a specific modulator of micro-calpain. Acyl-CoA-binding protein is proposed as a new component of the Ca(2+)-dependent proteolytic system. A comparative analysis among levels of classic calpains and their activator proteins is also reported.


Asunto(s)
Calpaína/metabolismo , Proteínas Portadoras/metabolismo , Músculo Esquelético/enzimología , Secuencia de Aminoácidos , Animales , Proteínas Portadoras/genética , Inhibidor de la Unión a Diazepam , Activación Enzimática , Activadores de Enzimas/metabolismo , Isoenzimas/metabolismo , Datos de Secuencia Molecular , Proteínas de Neoplasias/análisis , Ratas , Proteínas Recombinantes/metabolismo , Distribución Tisular
7.
Biochem J ; 325 ( Pt 3): 721-6, 1997 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-9271093

RESUMEN

The results presented provide more information on the sequential mechanism that promotes the Ca2+-induced activation of human erythrocyte mu-calpain under physiological conditions. The primary event in this process corresponds to the binding of Ca2+ to eight interacting sites, of which there are four in each of the two calpain subunits. Progressive binding of this metal ion is linearly correlated with the dissociation of the proteinase, which reaches completion when all eight binding sites are occupied. The affinity for Ca2+ in the native heterodimeric calpain is increased 2-fold in the isolated 80 kDa catalytic subunit, but it reaches a Kd consistent with the physiological concentration of Ca2+ only in the active autoproteolytically derived 75 kDa form. Binding of Ca2+ in physiological conditions, and thus the formation of the 75 kDa subunit, can occur only in the presence of positive modulators. These are represented by the natural activator protein, found to be a Ca2+-binding protein, and by highly digestible substrates. The former produces a very large increase in the affinity of calpain for Ca2+, and the latter a smaller but still consistent decrease in the Kd of the proteinase for the metal ion. As a result, both dissociation into the constituent subunits and the autoproteolytic conversion of the native 80 kDa subunit into the active 75 kDa form can occur within the physiological fluctuations in Ca2+ concentration. The delay in the expression of the proteolytic activity with respect to Ca2+ binding to native calpain, no longer detectable in the 75 kDa form, can be attributed to a Ca2+-induced functional conformational change, which is correlated with the accessibility of the active site of the enzyme.


Asunto(s)
Proteínas de Unión al Calcio/sangre , Calpaína/sangre , Eritrocitos/metabolismo , Animales , Biopolímeros , Calcio/sangre , Proteínas de Unión al Calcio/química , Calpaína/química , Catálisis , Humanos , Hidrólisis , Unión Proteica , Conformación Proteica , Ratas
8.
Biochem Biophys Res Commun ; 229(1): 193-7, 1996 Dec 04.
Artículo en Inglés | MEDLINE | ID: mdl-8954105

RESUMEN

The Ca-induced autoproteolysis calpain proceeds through the sequential formation of two forms of active enzyme with molecular masses of 78 kD and 75 kD, respectively. The autolysed calpains are produced by the cleavage of the peptide bond between Ser15-Ala16 and then between Gly27-Leu28. Calpastatin reduces with high efficiency the transition from 78 kD to 75 kD calpain forms. At higher concentration also the first autolytic event is blocked. The data are consistent with the presence of two calpain forms with different susceptibility to calpastatin. Furthermore, calpain, once bound to phospholipid vesicles, undergoes autoproteolysis which preferentially accumulates the 78 kD species. These data provide new information on the activation process of calpain, indicating that a Ca-induced conformational change is the triggering event, followed by the appearance of the active 78 kD calpain which can be considered the preferential form of calpain at the membrane level.


Asunto(s)
Proteínas de Unión al Calcio/farmacología , Calpaína/metabolismo , Inhibidores de Cisteína Proteinasa/farmacología , Fosfolípidos/farmacología , Secuencia de Aminoácidos , Autólisis , Calpaína/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Eritrocitos/química , Eritrocitos/enzimología , Humanos , Liposomas , Modelos Biológicos , Datos de Secuencia Molecular
9.
FEBS Lett ; 392(1): 11-5, 1996 Aug 19.
Artículo en Inglés | MEDLINE | ID: mdl-8769305

RESUMEN

The 80 kDa human erythrocyte calpain, when exposed to Ca2+, undergoes autoproteolysis that generates a 75 kDa species, with an increase in Ca2+ affinity. It is demonstrated here that this proteolytic modification proceeds through an initial step producing a 78 kDa form which is rapidly converted to the 75 kDa one. In the presence of the calpain inhibitor E-64, the 78 kDa form accumulates and only small amounts of the 75 kDa polypeptide are formed. Following loading of erythrocytes with micromolar concentration of Ca2+, in the presence of the ionophore A23187, the native 80 kDa calpain subunit is extensively translocated and retained at the plasma membrane, this process is accompanied by the appearance of only a small amount of the 75 kDa subunit which is released into the soluble fraction of the cells. Following exposure to microM Ca2+, membrane-bound 80 kDa calpain is converted to the 78 kDa form, this conversion being linearly correlated with the expression of the proteinase activity. Taken together, these results demonstrate that the initial step in calpain activation involves Ca(2+)-induced translocation to the inner surface of plasma membranes. In the membrane-bound form the native inactive 80 kDa subunit is converted through intramolecular autoproteolysis to a locally active 78 kDa form. Further autoproteolytic intermolecular digestion converts the 78 kDa to the 75 kDa form, no longer being retained by the membrane. This process generates two active forms of calpain, with different intracellular localisations.


Asunto(s)
Calpaína/metabolismo , Eritrocitos/enzimología , Calcio/metabolismo , Calpaína/antagonistas & inhibidores , Calpaína/aislamiento & purificación , Catálisis , Inhibidores de Cisteína Proteinasa/farmacología , Globinas/metabolismo , Humanos , Leucina/análogos & derivados , Leucina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA